157 related articles for article (PubMed ID: 29802828)
1. Jacareubin inhibits FcεRI-induced extracellular calcium entry and production of reactive oxygen species required for anaphylactic degranulation of mast cells.
Castillo-Arellano JI; Guzmán-Gutiérrez SL; Ibarra-Sánchez A; Hernández-Ortega S; Nieto-Camacho A; Medina-Campos ON; Pedraza-Chaverri J; Reyes-Chilpa R; González-Espinosa C
Biochem Pharmacol; 2018 Aug; 154():344-356. PubMed ID: 29802828
[TBL] [Abstract][Full Text] [Related]
2. Fyn kinase controls FcepsilonRI receptor-operated calcium entry necessary for full degranulation in mast cells.
Sanchez-Miranda E; Ibarra-Sanchez A; Gonzalez-Espinosa C
Biochem Biophys Res Commun; 2010 Jan; 391(4):1714-20. PubMed ID: 20043875
[TBL] [Abstract][Full Text] [Related]
3. Polydatin (PD) inhibits IgE-mediated passive cutaneous anaphylaxis in mice by stabilizing mast cells through modulating Ca²⁺ mobilization.
Yuan M; Li J; Lv J; Mo X; Yang C; Chen X; Liu Z; Liu J
Toxicol Appl Pharmacol; 2012 Nov; 264(3):462-9. PubMed ID: 22959927
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of parthenolide on antigen-induced microtubule formation and degranulation in mast cells.
Miyata N; Gon Y; Nunomura S; Endo D; Yamashita K; Matsumoto K; Hashimoto S; Ra C
Int Immunopharmacol; 2008 Jun; 8(6):874-80. PubMed ID: 18442792
[TBL] [Abstract][Full Text] [Related]
5. Natural vanadium-containing Jeju groundwater inhibits immunoglobulin E-mediated anaphylactic reaction and suppresses eicosanoid generation and degranulation in bone marrow derived-mast cells.
Li X; Lu Y; Yang JH; Jin Y; Hwang SL; Chang HW
Biol Pharm Bull; 2012; 35(2):216-22. PubMed ID: 22293352
[TBL] [Abstract][Full Text] [Related]
6. Blunted IgE-mediated activation of mast cells in mice lacking the Ca2+-activated K+ channel KCa3.1.
Shumilina E; Lam RS; Wölbing F; Matzner N; Zemtsova IM; Sobiesiak M; Mahmud H; Sausbier U; Biedermann T; Ruth P; Sausbier M; Lang F
J Immunol; 2008 Jun; 180(12):8040-7. PubMed ID: 18523267
[TBL] [Abstract][Full Text] [Related]
7. A novel imidazo[1,5-b]isoquinolinone derivative, U63A05, inhibits Syk activation in mast cells to suppress IgE-mediated anaphylaxis in mice.
Kim DK; Lee JH; Kim JW; Kim HS; Kim AR; Kim BK; Yi KY; Park HJ; Park DK; Choi WS
J Pharmacol Sci; 2011; 115(4):500-8. PubMed ID: 21498955
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide enhances FcεRI-mediated mast cell degranulation by increasing Ca2+ entry through store-operated Ca2+ channels: implications for lipopolysaccharide exacerbating allergic asthma.
Yang C; Mo X; Lv J; Liu X; Yuan M; Dong M; Li L; Luo X; Fan X; Jin Z; Liu Z; Liu J
Exp Physiol; 2012 Dec; 97(12):1315-27. PubMed ID: 22581748
[TBL] [Abstract][Full Text] [Related]
9. FcepsilonRI- and Fcgamma receptor-mediated production of reactive oxygen species by mast cells is lipoxygenase- and cyclooxygenase-dependent and NADPH oxidase-independent.
Swindle EJ; Coleman JW; DeLeo FR; Metcalfe DD
J Immunol; 2007 Nov; 179(10):7059-71. PubMed ID: 17982097
[TBL] [Abstract][Full Text] [Related]
10. Houttuynia cordata water extract suppresses anaphylactic reaction and IgE-mediated allergic response by inhibiting multiple steps of FcepsilonRI signaling in mast cells.
Han EH; Park JH; Kim JY; Jeong HG
Food Chem Toxicol; 2009 Jul; 47(7):1659-66. PubMed ID: 19394399
[TBL] [Abstract][Full Text] [Related]
11. Emodin, a naturally occurring anthraquinone derivative, suppresses IgE-mediated anaphylactic reaction and mast cell activation.
Lu Y; Yang JH; Li X; Hwangbo K; Hwang SL; Taketomi Y; Murakami M; Chang YC; Kim CH; Son JK; Chang HW
Biochem Pharmacol; 2011 Dec; 82(11):1700-8. PubMed ID: 21907188
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of xanthones isolated from the pericarp of Garcinia mangostana L. on rat basophilic leukemia RBL-2H3 cell degranulation.
Itoh T; Ohguchi K; Iinuma M; Nozawa Y; Akao Y
Bioorg Med Chem; 2008 Apr; 16(8):4500-8. PubMed ID: 18328716
[TBL] [Abstract][Full Text] [Related]
13. Increased IgE-dependent mast cell activation and anaphylactic responses in mice lacking the calcium-activated nonselective cation channel TRPM4.
Vennekens R; Olausson J; Meissner M; Bloch W; Mathar I; Philipp SE; Schmitz F; Weissgerber P; Nilius B; Flockerzi V; Freichel M
Nat Immunol; 2007 Mar; 8(3):312-20. PubMed ID: 17293867
[TBL] [Abstract][Full Text] [Related]
14. Zinc is required for Fc epsilon RI-mediated mast cell activation.
Kabu K; Yamasaki S; Kamimura D; Ito Y; Hasegawa A; Sato E; Kitamura H; Nishida K; Hirano T
J Immunol; 2006 Jul; 177(2):1296-305. PubMed ID: 16818790
[TBL] [Abstract][Full Text] [Related]
15. Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses.
Akimoto M; Mishra K; Lim KT; Tani N; Hisanaga SI; Katagiri T; Elson A; Mizuno K; Yakura H
Scand J Immunol; 2009 May; 69(5):401-11. PubMed ID: 19508371
[TBL] [Abstract][Full Text] [Related]
16. Inula japonica extract inhibits mast cell-mediated allergic reaction and mast cell activation.
Lu Y; Li Y; Jin M; Yang JH; Li X; Chao GH; Park HH; Park YN; Son JK; Lee E; Chang HW
J Ethnopharmacol; 2012 Aug; 143(1):151-7. PubMed ID: 22728246
[TBL] [Abstract][Full Text] [Related]
17. Effects of arachidonic acid analogs on FcepsilonRI-mediated activation of mast cells.
Nakano N; Nakao A; Uchida T; Shirasaka N; Yoshizumi H; Okumura K; Tsuboi R; Ogawa H
Biochim Biophys Acta; 2005 Dec; 1738(1-3):19-28. PubMed ID: 16403671
[TBL] [Abstract][Full Text] [Related]
18. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial Ca2+ flux is a critical determinant of the Ca2+ dependence of mast cell degranulation.
Suzuki Y; Yoshimaru T; Inoue T; Ra C
J Leukoc Biol; 2006 Mar; 79(3):508-18. PubMed ID: 16365155
[TBL] [Abstract][Full Text] [Related]
20. Concurrent inhibition of kit- and FcepsilonRI-mediated signaling: coordinated suppression of mast cell activation.
Jensen BM; Beaven MA; Iwaki S; Metcalfe DD; Gilfillan AM
J Pharmacol Exp Ther; 2008 Jan; 324(1):128-38. PubMed ID: 17925481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
